Dr. Szewczuk is
Full Professor of Immunology and Medicine over 38 years at Queenâ€™s University,
Kingston, Ontario Canada. Dr. Szewczukâ€™s research has focused on the role of
glycosylation in receptor activation with a particular focus of Toll-like,
neurotrophin Trk, EGFR and insulin
receptors. A novel receptor-signalling platform was discovered, and its
targeted translation in multistage tumorigenesis. He is now in the development
of engineered drug delivery systems.
Copyright © Madridge 2019. All rights reserved.